Baxter International adds ENFit to its portfolio

Baxter International, the company focused on nutrition therapy, has expand its nutrition care portfolio to include the new enteral ENFit syringe and accessory line for patients requiring tube feeding.

Baxter’s enteral ENFit syringes are designed to improve patient safety during enteral nutrition (EN) therapy by preventing misconnections or wrong-route administration, which can cause severe patient injury.

The company explained that EN therapy delivers vital nutrients, including protein, carbohydrates, fats, water, minerals and vitamins directly to the patient’s intestinal tract via a tube.

Baxter plans to launch its enteral ENFit syringes and accessories in the United States, Canada, select European countries, Australia and New Zealand in 2017.